Everence Capital Management’s Enphase Energy ENPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$242K Buy
+4,913
New +$224K 0.01% 737
2025
Q2
Sell
-4,910
Closed -$305K 804
2025
Q1
$305K Sell
4,910
-1,940
-28% -$123K 0.02% 558
2024
Q4
$470K Buy
+6,850
New +$544K 0.03% 382
2023
Q3
Sell
-2,690
Closed -$468K 753
2023
Q2
$468K Hold
2,690
0.04% 364
2023
Q1
$566K Sell
2,690
-330
-11% -$71.5K 0.05% 333
2022
Q4
$800K Sell
3,020
-1,100
-27% -$320K 0.07% 249
2022
Q3
$1.14M Hold
4,120
0.11% 167
2022
Q2
$804K Hold
4,120
0.07% 221
2022
Q1
$831K Hold
4,120
0.06% 245
2021
Q4
$754K Buy
+4,120
New +$860K 0.06% 286
2021
Q3
Sell
-3,550
Closed -$652K 745
2021
Q2
$652K Hold
3,550
0.05% 307
2021
Q1
$576K Buy
+3,550
New +$637K 0.05% 319

Other funds holding ENPH

Everence Capital Management's ENPH Position: Q2 2026 in Review

Everence Capital Management opened a new position in Enphase Energy (ENPH) in Q2 2026: 4,913 shares worth $242K. The stake represents 0.01% of the portfolio and ranks #737 among its holdings. This is a return to the name: Everence Capital Management previously reported a position in ENPH as recently as Q1 2025.

Everence Capital Management first reported a position in ENPH in Q1 2021 and has held it in 12 quarters since. The position peaked at $1.14M in Q3 2022. 537 funds tracked by Wall St. Rank hold ENPH as of Q2 2026.

  • Everence Capital Management held 4,913 shares of Enphase Energy worth $242K as of Q2 2026.
  • Enphase Energy was a new Everence Capital Management position in Q2 2026.
  • Enphase Energy made up 0.01% of Everence Capital Management's portfolio in Q2 2026, its #737 holding.
  • Everence Capital Management first reported a position in Enphase Energy in Q1 2021 and has held it in 12 quarters since.
  • Everence Capital Management's Enphase Energy position peaked at $1.14M in Q3 2022.
  • 537 funds tracked by Wall St. Rank held Enphase Energy as of Q2 2026.

Based on Everence Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.